Status of clinical hyperthermia

Acta Oncologica

Volumn 38, Issue 7, 1999, Pages 863-873

  Dahl, Olav ^a   Dalene, Ronny ^a   Schem, Baard Christian ^a   Mella, Olav ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HYPERTHERMIC THERAPY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; THERMOMETRY;

BREAST NEOPLASMS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; NEOPLASMS; RECTAL NEOPLASMS;

EID: 0032757889     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432554     Document Type: Article

References (109)

1. Dahl O, Overgaard J. A century with hyperthermic oncology in Scandinavia. Acta Oncol 1995; 34: 1075-83.
2. Urano M, Douple E. Thermal effects on cells and tissues. In: Hyperthermia and oncology. Utrecht: VSP, 1988; 1: 1-214.
3. Seegenschmiedt MH, Fessenden P, Vernon CC. Thermoradiotherapy and thermochemotherapy. Vol. 1 Biology physiology and physics. Philadelphia/Berlin: Springer Verlag, 1995: 1-483.
4. Multhoff G, Hightower LE. Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones 1996; 1: 167-76.
5. Fuse T, Yoon K-W, Kato T, Yamada K. Heat-induced apoptosis in human glioblastoma cell line A172. Neurosurgery 1998; 42: 843-9.
6. Takasu T, Lyons JC, Park HJ, Song CW. Apoptosis and perturbation of cell cycle progression in an acidic environment after hyperthermia. Cancer Res 1998; 58: 2504-8.
7. Toyota N, Strebel FR, Stephens LC, et al. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin combined with whole-body hyperthermia in a rat mammary adenocarcinoma. Int J Cancer 1998; 76: 499-505.
8. Fajardo LF, Prionas SD, Kowalski J, K\van HK. Hyperthermia inhibits angiogenesis. Radial Res 1988; 114: 297306.
9. Overgaard J. The current and potential role of hyperthermia in radiotherapy. Irit J Radiât Oncol Biol Phys 1989; 16: 535-49.
10. Dahl O. Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E, eds. Hyperthermia and oncology. Utrecht: VSP. Vol 1994; 4: 28-49.
11. Dahl O. Interaction of heat and drugs in vitro and in vivo. In: Seegenschmiedt MH, Fessenden P, Vernon CC, eds. Medical radiology-diagnostic imaging and radiation oncology. Berlin: Springer Verlag, ; Vol l, 1995: 103-21.
12. Overgaard J, Gonzalez Gonzalez D, Hulshof MCCH, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3-20.
13. Sneed PK, Stauffer RP, McDermott M\V, et al. Survival benefit of hyperthermia in a prospective randomized trial of branchytherapy boost hyperthermia for glioblastoma multiforme. Int J Radiât Oncol Biol Phys 1998; 40: 287-95.
14. Leopold KA, Dewhirst M, Samulski T, et al. Relationships among tumor temperature, treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas. Int J Radiât Oncol Biol Phys 1992; 22: 989-98.
15. Field SB, Morris CC. The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol 1983; 1: 179-86.
16. Sapareto SA, Dewey \VC. Thermal dose determination in cancer therapy. Int J Radiât Oncol Biol Phys 1984; 10: 787-800.
17. Leopold KA, Dewhirst MW, Samulski TV, et al. Cumulative minutes with T90 greater than tempinjcx is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiât Oncol, Biol. Phys 1993; 25: 841-7.
18. van der Zee J, Peer-Valstar JN, Rietveld PJM, de GraafStrukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiât Oncol Biol Phys 1998; 40: 1205-12.
19. Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radial Oncol Biol Phys 1998; 41: 1129-37.
20. Hand JW, Lagendijk JJW, Bach Andersen J, Bolomey JC. Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 1989; 5: 421-8.
21. Lagendijk JJW, van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperlhermia. Inl J Hyperthermia 1998; 14: 125-33.
22. Dewhirst MV, Phillips TL, Samulski TV, et al. RTOG quality guidelines for clinical trials using hyperthermia. Int J Radiât Oncol Biol Phys 1990; 18: 1249-59.
23. Carter DL, MacFall JR, Clegg ST, et al. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int J Radiât Oncol Biol Phys 1998; 40: 815-22.
24. Sennewald G, Turner PF, Schaefermeyer T, Latta M, Lauritzen R. Non-invasive treatment monitoring using a BSDSigma eye incorporated with a MRI system. In: Franconi C, Arcangeli G, Cavalière R, eds. Hyperthermic oncology 1996; Vol 2: 412-3.
25. Dewhirst MW, Prosnitz L, Thrall D, et al. Hyperthermic treatment of malignant diseases: current status and a view toward the future. Semin Oncol 1997; 24: 616-25.
26. Kapp DS, Petersen IA, Cox RS, et al. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. Int J Radiât Oncol Biol Phys 1990; 19: 1481-95.
27. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiât Oncol Biol Phys 1994; 28: 163-9.
28. Overgaard J, Nielsen OS. The importance of thermotolerance for the clinical treatment with hyperthermia. Radiother Oncol 1983; 1: 167-78.
29. Emami B, Myerson RJ, Cardenes H, et al. Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (I/wk vs 2/wk). Int J Radiât Oncol Biol Phys 1992; 24: 145-52.
30. Engin K, Tupchong L, Moylan DJ, et al. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. Int J Hyperthermia 1993; 9: 327-30.
31. Sullivan DM, Ben-Yosef R, Kapp DS. Stanford 3D hyperthermia treatment planning system. Technical review and clinical summary. Int J Hyperthermia 1993; 9: 627-43.
32. Hornsleth SN. Radiofrequency regional hyperthermia. Heating technology, quality assurance, treatment planning. Thesis. Bergen: Bergen University, 1996.
33. Wust P, Seebass M, Nabodny J, Deuflhard P, Mönich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia 1996; 12: 477-94.
34. Turner PF, Schaefermeyer T, Saxton T. Future trends in heating technology of deep-seated tumors. Recent Results Cancer Res 1988; 107: 249-62.
35. Dahl EO. Quality assurance system for the BSD 2000 hyperthermia system. Thesis. Bergen: University of Bergen, 1998: 1-115.
36. Hornsleth SN, Frydendal L, Mella O, Dahl O, Raskmark P. Quality assurance for radio frequency regional hyperthermia. Int J Hyperthermia 1997; 13: 169-85.
37. Myerson RJ, Perez CA, Emami B, et al. Tumor control in long-term survivors following superficial hyperthermia. Int J Radiât Oncol Biol Phys 1990; 18: 1123-9.
38. Petrovich Z, Langholz B, Gibbs FA, et al. Regional hyperthermia for advanced tumors: a clinical study of 353 patients. Int J Radiât Oncol Biol Phys 1989; 16: 601-7.
39. Sapozink MD, Joszef G, Astrahan MA, Gibbs Jr. FA, Petrovich Z, Stewart JR. Adjuvant pelvic hyperthermia in advanced cervical carcinoma. I. Feasibility, thermometry and device comparison. Int J Hyperthermia 1990; 6: 985-96.
40. Feldmann HJ, Molls M, Heinemann H-G, Romanowski R, Stuschke M, Sack H. Thermoradiotherapy in locally advancecl deep seated tumours-thermal parameters and treatment results. Radiother Oncol 1993; 26: 38-44.
41. Overgaard J, Bach Andersen J. Hyperthermia. In: Peckham M, Pinedo H, Veronesi U, eds. Oxford textbook of oncology. Oxford: Oxford University Press, 1995; Vol 1: 1823-35.
42. Overgaard J, Gonzalez DG, Hulshof MCCM, et al. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540-3.
43. Lindholm C-E, Kjellen E, Nilsson P, Hertzman S. Microwave-induced hyperthermia and radiotherapy in human superficial tumours: clinical results with a comparative study of combined treatment versus radiotherapy alone. Int J Hyperthermia 1987; 3: 393-411.
44. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiât Oncol Biol Phys 1996; 35: 731-44.
45. van der Zee J, van der Holt B, Rietveld P, et al. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 1999; 79: 483-90.
46. Arcangeli G, Barni E, Cividalli A, et al. Effectiveness of microwave hyperthermia combined with ionizing radiation: clinical results on neck node métastases. Int J Radial Oncol Biol Phys 1980; 6: 143-8.
47. Valdagni R, Kapp DS, Valdagni C. N3 (TNM-UICC) metastatic neck nodes managed by combined radiation therapy and hyperthermia: clinical results and analysis of treatment parameters. Int J Hyperthermia 1986; 2: 189-200.
48. Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiât Oncol Biol Phys 1988; 15: 13-24.
49. Amichetti M, Romano M, Busana L, et al. Hyperfractionated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: a phase I-II study. Radiother Oncol 1997; 45: 155-8.
50. Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 6: 479-86.
51. Overgaard J, van der Zee J, Vernon C, Gonzalez Gonzalez D, Arcangeli G. Thermoradiotherapy of malignant tumors. European randomized multicenter trials evaluating the effect of adjuvant hyperthermia in radiotherapy. In: Kogelnik HD, ed. 5th International Meeting on Progress in Radio-Oncology ICRO/ÖGRO 5. Salzburg (Austria): Monduzzi Editore SpA, 1995: 507-13.
52. Kapp DS. Editorial comment: a phase III study on hyperthermia in head and neck canine tumours: not hot enough. Int J Hyperthermia 1996; 12: 437-41.
53. Wust P, Stahl H, Dieckmann K, et al. Local hyperthermia of N2/N3 cervical lymph node métastases: correlation of technical/thermal parameters and response. Int J Radiât Oncol Biol Phys 1996; 34: 635-46.
54. Stahl H, Wust P, Graf R, et al. Phase-1/II- Studie zur lokalen Hyperthermie zervikaler N2/N3- Lymphknotenmetastasen. Strahlenther Onkol 1997; 173: 219-29.
55. Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Am J Clin Oncol 1991; 14: 133-41.
56. Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperthermia and their impact on local therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiât Oncol Biol Phys 1989; 16: 551-8.
57. van der Zee J, GonzalesGonzales D, Vernon CC, et al. Therapeutic gain by hyperthermia added to radiotherapy. In: Kogelnik HD, Sedlmayer E, eds. 'Progress in radio-oncology VI.' Bologna: Monduzzi Editore, 1998: 137-145.
58. Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE. Long-term results of treatment of cervical carcinoma in the United States in , 1978 and 1983: patterns of care study (PCS). Int J Radiât Oncol Biol Phys ; 31 -1973; 1995: 973-82.
59. Takeshi K, Katsuyuki K, Yoshiaki T, et al. Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiât Oncol Biol Phys 1998; 41: 319-27.
60. Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-doserate brachytherapy. Int J Radiât Oncol Biol Phys 1998; 42: 531-40.
61. Perez CA, Grigsby PW, Chao KSC, Mutch DO, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiât Oncol Biol Phys 1998; 41: 307-17.
62. Leborgne F, Leborgne JH, Doldân R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radial Oncol Biol Phys 1997; 37: 343-50.
63. Shueng P, Hsu W, Jen Y, Wu C, Liu H. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int J Radiât Oncol Biol Phys 1998; 40: 889-96.
64. Zanetta G, Lissoni A, Pellegrino A, et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998; 9: 977-80.
65. Mella O, Dahl O, Horn A, Morild I, Ödland G. Radiotherapy and resection for apparently inoperable rectal adenocarcinoma. Dis Colon Rectum 1984; 27: 663-8.
66. Rau B, Wust P, Hohenberger P, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. Ann Surg 1998; 227: 380-9.
67. Wust P, Rau B, Gellermann J, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. Cancer Res 1998; 146: 175-91.
68. Korenaga D, Matsushima T, Adachi Y, et al. Preoperative hyperthermia combined with chemotherapy and radiotherapy for patients with rectal carcinoma may prevent early local pelvic recurrence. Int J Colored Dis 1992; 7: 206-9.
69. Ohno S, Tomoda M, Tomisaki S, et al. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum 1997; 40: 401-6.
70. Trotter JM, Edis AJ, Blackwell JB, et al. Adjuvant VHP therapy in locally recurrent and primary unresectable rectal cancer. Australas Radiol 1996; 40: 298-305.
71. Berdov BA, Menteshashvili GZ. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990; 6: 881-90.
72. You Q-S, Wang R-Z, Suen G-Q, et al. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: long-term results of 44 patients. Int J Hyperthermia 1993; 9: 19-24.
73. Heald RJ, Ryall RDM. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; Jun 28, 1: 1479-82.
74. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.
75. Strotsky A, Fradkin S, Zhavrid E, Karpovich U. Combined therapy of bladder cancer with the use of hyperthermia. Strahlenther Onkol 1991; 167: 346.
76. Seegenschmiedt MH, Klautke G, Seidel R, Stauffer P. Clinical practice of. interstitial thermoradiotherapy. In: Seegenschmiedt MH, Fessenden P, Vernon CC, eds. Thermoradiotherapy and thermochemotherapy. Vol 2. Clinical applications. Berlin: Springer, 1995: 207-62.
77. Emami B, Scott C, Perez CA, et-al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiât Oncol Biol Phys 1996; 34: 1097-104.
78. Ueo H, Sugimachi K. Preoperative hyperthermochemoradiotherapy for patients with esophageal carcinoma or rectal carcinoma. Semin Surg Oncol 1990; 6: 8-13.
79. Sugimachi K, Kitamura K, Baba K, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus-a prospective randomized trial. Int J Hyperthermia 1992; 8: 289-95.
80. Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 1994; 10: 485-93.
81. Kitamura K, Kuwano H, Watanabe M, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55-8.
82. Issels RD, Mittermüller J, Gerl A, et al. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients. J Cancer Res Clin Oncol 1991; 117: S141-7.
83. Issels RD, Bosse D, Starck M, et al. Weichteiltumoren: Indikation und ergebnisse der Hyperthermie. Chirurg 1993; 64: 461-7.
84. Issels RD, Bosse D, Abdel-Rahman S, et al. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma. A pilot study. Cancer Chemother Pharmacol 1993; 31: S233-7.
85. Multhoff G, Botzler C, Wiesnet M, et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995; 61: 272-9.
86. Kim JH, Hahn EW, Antich PP. Radiofrequency hyperthermia for clinical cancer therapy. Natl Cancer Inst Monogr 1982; 61: 339-42.
87. Petersen IA, Kapp DS. Local hyperthermia and radiation therapy in the retreatment of superficially located recurrences in Hodgkin's disease. Int J Radiât Oncol Biol Phys 1990; 18: 603-11.
88. Donato V, Zurlo A, Nappa M, et al. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin's lymphomas. J Exp Clin Res 1997; 16: 87-90.
89. Colombo R, Lev A, Freschi M, Gallus G, Rigatti P. Neoadjuvant combined microwave-induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol 1996; 155: 1227-32.
90. Arcangeli G, Cividalli A, Mauro F, Nervi C, Pavin G. Enhanced effectiveness of adriamycin and bleomycin combined with local hyperthermia in neck node métastases from head and neck cancers. Tumori 1979; 65: 481-6.
91. Pilepich MV, Jones KG, Emami BN, Ferez ÇA, Fields JN, Myerson RJ. Interaction of bleomycin and hyperthermiaresults of a clinical pilot study. Int J Radiât Oncol Biol Phys 1989; 16: 211-3.
92. Cumberlin R, De Moss E, Lassus M, Friedman M. Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 1985; 3: 1022-31.
93. Lejeune FJ, Deloof T, Ewalenko P, et al. Objective regression of unexcised melanoma in-transit métastases after hyperthermic isolation perfusion of the limbs with melphalan. Recent Results Cancer Res 1983; 86: 268-2676.
94. Lienard D, Lejeune FJ, Ewalenko P. In transit métastases of malignant melanoma treated by high dose rTNFalpha in combination with interferon-y and melphalan in isolation perfusion. World J Surg 1992; 16: 234-40.
95. Ghussen F, Krüger I, Groth W, Stützer H. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 1988; 61: 654-9.
96. Ghussen F, Krüger I, Smalley RV, Groth W. Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World J Surg 1989; 13: 598-602.
97. Hafström L, Rudenstam C-M, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol 1991; 9: 2091-4.
98. Koops HS, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized high-risk limb melanoma: results of a multicenter randomized phase III trial. J Clin Oncol 1998; 16: 2906-12.
99. Klicks RJ, Vrouenraets BC, Nieweg OE, Kroon BBR. Vascular complications of isolated limb perfusion. Eur J Surg Oncol 1998; 24: 288-2891.
100. Cavalière R, Di Filippo F, Cavalière F, et al. Clinical practice of hyperthermic extremity perfusion in combination with radiotherapy and chemotherapy. In: Seegenschmiedt MH, Fessenden P, Vernon CC, eds. Thermoradiotherapy and thermochemotherapy. Berlin: Springer. Vol 1995; 2: 323-45.
101. Pettigrew R, Lugate C. Whole-body hyperthermia. A systemic treatment for disseminated cancer. Recent Results Cancer Res 1977; 59: 153-70.
102. van der Zee J, van Rhoon GC, Wike-Hooley J, Faithful! N, Reinhold H. Whole-body hyperthermia in cancer therapy: a report of a phase I-II study. European Journal of Clinical Oncology 1983; 19: 1189-200.
103. Bull JM, Lees D, Schuette W, et al. Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med 1979; 90: 317-23.
104. Robins HI. Role of whole-body hyperthermia in the treatment of neoplastic disease: its current status and future prospects. Cancer Res 19S4; 44: 4878S-4883.
105. Engelhardt R, Müller U, Weth-Simon R, Neumann HA, Löhr GW.' Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. Int J Hyperthermia 1990; 6: 511-5.
106. Wiedemann G, Robins H, Gutsche S, et al. Ifosfamide, carboplatin and etoposide (ICE) combined with 4I.8C whole body hyperthermia in patients with refractory sarcoma. Eur J Cancer 1996; 32A: 888-92.
107. Robins H, Rushing D, Kutz M, et al. Phase I clinical trial of melphalan and 41.8C whole-body hyperthermia in cancer patients. J Clin Oncol ; 15. 1997: 158-64.
108. Engelhardt R. Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy. Recent Results Cancer Res 1988; 107: 200-4.
109. Lindholm C-E, Kjellén E, Nilsson P, Weber L, Hill S. Prognostic factors for tumour response and skin damage to combined radiotherapy and hyperthermia in superficial recurrent breast carcinomas. Int J Hyperthermia 1995; 11: 337-55.